Actively Recruiting

Age: 18Years - 75Years
All Genders
NCT04037995

Real World Study of End-stage Liver Disease in China

Led by Huashan Hospital · Updated on 2019-07-30

10000

Participants Needed

1

Research Sites

521 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The aims of this study are exploring the current situation of end-stage liver disease in China, and the optimization of diagnosis and treatment. Liver cirrhosis often accompanied by a series of complications. Therefore, it is necessary to standardize the diagnosis and treatment of liver cirrhosis and its complications. End-stage liver disease mainly refers to the late stage of liver disease caused by various chronic liver damage. Its main feature is that liver function can not meet the physiological needs of human body. This study is a single-center, prospective and observational real-world study aimed at investigating and analyzing the current diagnosis and treatment of liver cirrhosis and end-stage liver disease in China.

CONDITIONS

Official Title

Real World Study of End-stage Liver Disease in China

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients must give informed consent.
  • Diagnosis of acute decompensation of cirrhosis, chronic and acute liver failure, chronic liver failure, or hepatocellular carcinoma (stage III-IV).
Not Eligible

You will not qualify if you...

  • HIV positive or AIDS patients.
  • History of serious psychiatric illness, including major depression, psychosis, suicide attempts, hospitalization due to mental illness, or disability from mental illness.
  • Serious diseases affecting heart, lung, kidney, brain, blood, or other important organs.
  • Presence of other malignant tumors except those cured.
  • Pregnant, breastfeeding, or women of childbearing age planning to conceive.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

HuaShan Hospital

Shanghai, Shanghai Municipality, China, 200040

Actively Recruiting

Loading map...

Research Team

J

Jingwen Ai, Doctor

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here